FEASIBILITY AND SAFETY OF TRANSABDOMINAL CHORIONIC VILLUS SAMPLING

Authors

  • Abeera Choudry
  • Saima Masood
  • Suhaib Ahmed

Abstract

Background: Chorionic Villus Sampling (CVS) is the technique of choice for prenatal diagnosis prior to12 weeks gestation. The objective of this study was to determine the feasibility, and pattern ofcomplications following first trimester Trans-abdominal Chorionic Villus Sampling (TA-CVS).Methods: This was a descriptive study conducted in the Obstetrics and Gynaecology DepartmentMilitary Hospital (MH) Rawalpindi from Jan 2007 to July 2008. Couples at risk of giving birth to a childwith genetic disorder were identified and counselled. Trans-abdominal Chorionic Villus Sampling wasdone using double needle technique under ultrasound guidance. Immediate and late complications werefollowed up. Data was analysed using SPPS-10. Results: On 200 cases chorionic villus sampling wasdone as an outdoor procedure. Most common indication was thalassaemia trait 75 (37.5%). Mostprocedures were done between 12–13 weeks. All placental positions including 104 (52%) posterior and71 (35.5%) anterior were approachable. Most aspirations were easy, however, in 30 (15%) the aspirationwas difficult. Overall success rate was 100%. In 158 (79%) of the cases sample yield was good. One(0.5%) patient had vaginal bleeding and three (1.5%) had placental haematoma formation. Most patients(84%) experienced mild pain during the procedure. The procedure related miscarriage occurred in 2(1%) patients while another patient developed this complication after 6 weeks. Conclusion: Firsttrimester TA-CVS is an accurate and safe invasive prenatal diagnostic procedure. Placentas in almostany position can be approached without any significant risk to mother and the foetus.Keywords Prenatal diagnosis, thalassaemia, chorionic sampling

References

Cederholm M, Haglund B, Axelsson O. Maternal complications

following amniocentesis and chorionic villus sampling for prenatal

karyotyping. BJOG 2003;110:392–9.

Silver RK, Wilson RD, Philip J, Thom EA, Zachary JM, Mohide

P. Late first trimester placental disruption and subsequent

gestational hypertension/preeclampsia. Obstet Gynecol

;105:587–92.

Lau KT, Leung YT, Fung YT, Chan LW, Sahota DS, Leung NT

et al. Outcome of 1,355 consecutive transabdominal chorionic

villus sampling in 1,351 patients. Chin Med J (Engl)

;1180:1675–81.

Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and

chorionic villus sampling for prenatal diagnosis (Cochrane

Review). Cochrane Database Syst Rev 2003;(3):CD003252.

Arora S, Kabra M, Maheshwari M, Shastri S, Kaur D, Deka D et

al. Prenatal diagnosis of haemoglobinopathies. Natl Med J India

;14:340–2.

Ahmed S, Saleem M, Sultana N, Raashid Y, Waqar A, Anwar M

et al. Prenatal Diagnosis of beta-thalassaemia in Pakistan:

experience in a Muslim Country. Prenat Diagn 2000;20:378–83.

Wapner RJ. Invasive Prenatal Diagnostic Techniques. Semin

Perinatol 2005;29:401–4.

Brambati B, Tului L, Camurri L, Guercilena S. Early second

trimester (13–20 weeks) transabdominal chorionic villus sampling

(TA-CVS): a safe and alternative method for both high and low

risk population. Prenat Diagn 2002;22:907–13.

Stetten G, Escallon CS, South ST. Reevaluating confined

placental mosaicism. Am J Med Genet A 2004;131:232–9.

Muzejinovic F, Alfirevic Z. Procedure–related complicationsof

amniocentesis and chorionic villus sampling: a systemic review.

Obstet Gynecol 2007;110:687–94.

Odibo AO, Dicke JM, Gray DL, Oberle M, Stamimio DM,

Macones GA, et al. Evaluating the rate and risk factors for foetal

loss after chorionic villus sampling. Obstet Gynecol

;112:813–9.

Aaron B. Caughey, AB, Linda M. Hopkins, Mary E. Norton ME.

Chorionic villus sampling compared with amniocentesis and the

difference in the rate of preganancy loss. Obstet Gynecol

;108:612–6.

Brun JL, Mangione R, Gangbo F, Guyon F, Taine L, Roux D.

Feasibility, accuracy and safety of chorionic villus sampling: a

report of 10741 cases. Prenat Diagn 2003;23:295–301.

Chorionic villus sampling and amniocentesis: recommendations

for prenatal counseling. Centers for Disease Control and

Prevention. MMWR Recomm Rep 1995;44(RR-9):1–12.

Ball RH. Invasive foetal testing Curr Opin Obstet Gynecol

;16:159–62.

Antsaklis A, Souka AP, Daskalak is G, Kavalakis Y, Michalas S.

Second trimester amniocentesis vs chorionic villus sampling for

prenatal diagnosis in multiple gestations. Ultrasound Obstet

Gynecol 2002;20:476–81.

Brambati B Tului L, Cislaghi C, Alberti E. First 10,000 chorionic

villus samplings performed on singleton pregnancies by a single

operator. Prenat Diagn 1998;18:255–66.

Medical Research Council European trial of chorionic villus

sampling. MRC working party on the evaluation of chorion villus

sampling. Lancet 1991;337:1491–9.

Jackon LG, Zachary JM, Fowler SE, Desnick RJ, Golbus MS,

Ledbetter DH, et al. A randomized comparison of transcervical

and transabdominal chorionic villus sampling. The U.S National

Institute of Child Health and Human Development Chorionicvillus sampling and Amniocentesis Study Group. N Engl J Med

;327:594–8.

Schaap AH, Van der Pol HG, Boer K, Leschot NJ, Wolf H. Long

term follow up of infants after transcervical chorionic villus

sampling and after amniocentesis to compare congenital

abnormalities and health status. Prenat Diagn 2002;22:598–604.

Cederholm M, haglund B, Axelsson O. Infant morbidity following

amniocentesis and chorionic villus sampling for prenatal

karyotyping. BJOG 2005;112:394–402.

Ejskjaer KV, Sorensen AU, Johannesen PL, Praest J.

Amnoicentesis and chorionic villi biopsy: A 10 year material.

Ugeskr Laeger 2001;163:4750–3.

Papp C, Beke A, Mezei G, Toth–Pal E, Papp Z. Chorionic villus

sampling: a 15 year experience. Foetal Diagn Ther 2002;17:218–27.

Brambati B, Tului L, Guercilena S. Alberti E. Outcome of first

trimester chorionic villus sampling for genetic investigation in

multiple pregnancy. Ultrasound Obstet Gynecol 2001;17:209–16.

J Ayub Med Coll Abbottabad 2012;24(1)

http://www.ayubmed.edu.pk/JAMC/24-1/Abeera.pdf 43

Denise M, Humphrey H, Godelieve M, Wilma E, Hans J, Sicco

A. Fetomaternal hemorrhage in relation to chorionic villus

sampling revisited. Prenat Diagn 2006;26: 201–5.

Eddleman KA, Stone JL, Lynch. L, Berkowitz RL, Chorionic

villus sampling before multi foetal pregnancy reduction. Am J

Obstet Gynecol 2000;183:1078–81.

Harris RA, Washington AE, Nease RF, Kuppermann M. Cost

utility of prenatal diagnosis and the risk based threshold. Lancet

;363:276–82.

Ahmed H, Sultana N. Indications and complications of chorionic

villus sampling. Pak Armed Forces Med J 2005;55(1):3–7.

Dolkart L, Harter M, Synder M. Four–Dimensional

ultrasonographic guidance for invasive obstetric procedures. J

Ultrasound Med 2005;24:1261–6.

Wax JR, Carpenter M, Chard R, Cartin A, Pinette MG. Pain

associated with transabdominal chorionic villus sampling:

Anticipated versus actual. J Matern Foetal Neonat Med

;19:421–3.

Baig SM, Azhar A, Hassan H, Baig JM, Aslam M, Ud Din MA, et

al. Prenatal Diagnosis of beta thalassaemia in southern Punjab,

Pakistan. Prenat Diagn 2006;26:903–5.

Samavat A, Model B. Iranian National thalassaemia screening

programme. BMJ 2004;329:1134–7.

Eisenberg B, Wapner RJ. Clinical procedures in prenatal

diagnosis. Best Pract Res Clin Obstet Gynaecol 2002;16:611–27.

Downloads

Published

2012-03-01